Remdesivir for COVID-19 | Children’s asthma | Brain differences and waist size

Final report of remdesivir benefits for COVID-19; education programs for children's asthma; brain differences in youth tied to waist size

Having trouble viewing this email? View it as a Web page. October 20, 2020 Edition  COVID-19 is an emerging, rapidly evolving situation, and we at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines. You can find the latest public health information from CDC at www.coronavirus.gov and the latest research information from NIH at www.nih.gov/coronavirus. Meanwhile, science continues to progress on many other fronts, and we will continue to try to bring you stories across a wide range of topics. Final report confirms remdesivir benefits for COVID-19 The antiviral drug remdesivir shortened recovery time for patients hospitalized with COVID-19, based on results from the completed trial. Education programs may improve young children's asthma control A combination of health programs at school and home appeared to improve asthma control in preschool children from low-income families. Brain differences in youth linked to increased waist size Cellular differences in a brain area that plays a key role in reward and food processing may predict higher obesity in children. Popular Stories: Immune cells for common cold may recognize SARS-CoV-2   Experimental coronavirus vaccine is safe and produces immune response   Potent antibodies found in people recovered from COVID-19   SARS-CoV-2 may use key carbohydrate to infect cells   Beneficial bacteria prevent recurring bacterial vaginosis  Connect with us:  Facebook RSS Feed

Update Your E-mail Address | Add Subscriptions | Unsubscribe All If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health. NIH…Turning Discovery Into Health®

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612